Minocycline for patients with ALS

Lancet Neurol. 2008 Feb;7(2):118-9; author reply 120-1. doi: 10.1016/S1474-4422(08)70005-X.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't
  • Comment

MeSH terms

  • Amyotrophic Lateral Sclerosis / drug therapy*
  • Animals
  • Anti-Bacterial Agents / adverse effects
  • Anti-Bacterial Agents / therapeutic use*
  • Disease Models, Animal
  • Drug Therapy, Combination
  • Humans
  • Mice
  • Mice, Knockout
  • Minocycline / adverse effects
  • Minocycline / therapeutic use*
  • Randomized Controlled Trials as Topic
  • Superoxide Dismutase / genetics
  • Superoxide Dismutase-1
  • Treatment Failure

Substances

  • Anti-Bacterial Agents
  • SOD1 protein, human
  • Sod1 protein, mouse
  • Superoxide Dismutase
  • Superoxide Dismutase-1
  • Minocycline